Sally Coggins Webinars

Advances in FIP treatment, an Australian perspective (2021)

By Dr. Sally Coggins BVSc (hons I) MANZCVS (Feline Medicine)

Advances in anti-viral therapy are showing that effective treatment for FIP is finally now a reality.  Since 2018, publications emerged showing FIP remission states were being achieved with new antiviral compounds. Registered, commercial options remain unavailable, however, vets are now gaining legal access to the nucleoside analogue remdesivir via BOVA compounding pharmacy. Preliminary results are showing remission rates to be high (80%). The human registered antimalarial drug mefloquine may also hold promise for FIP treatment.  These drugs are currently the focus of prospective treatment trials being conducted by Sally through the Sydney School of Veterinary Science, The University of Sydney. During this webinar, Sally aims to update the general clinicians’ knowledge surrounding the use of these drugs in private practice; discuss the current treatment protocols commonly employed; highlight side-effects to look out for, and to discuss approaches to treatment failure.

Feline Infectious Peritonitis (FIP) – What we’ve learned so far! (2021)

By Dr. Sally Coggins BVSc (hons I) MANZCVS (Feline Medicine)

Advances in antiviral therapy are showing that effective treatment for FIP is finally now a reality. Since 2018, publications emerged showing FIP remission states were being achieved with new antiviral compounds. Registered, commercial options remain unavailable, however, vets are now gaining legal access to the nucleoside analogue Remdesivir via Bova Aus. During this webinar, Sally aims to update the general clinician’s knowledge surrounding the use of these drugs in private practice.